Inhibitor Therapeutics (INTI) Short Interest Ratio & Short Volume $0.05 0.00 (0.00%) As of 10/17/2025 Add Compare Share Share Short Interest Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock Inhibitor Therapeutics Short Interest DataInhibitor Therapeutics (INTI) has a short interest of 700 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 11,796 shares to cover all short positions.Current Short Interest700 sharesPrevious Short Interest700 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$34.79Short Interest Ratio0.1 Days to CoverLast Record DateSeptember 30, 2025Outstanding Shares172,570,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume10 sharesAverage Trading Volume11,796 sharesToday's Volume Vs. Average0% Short Selling Inhibitor Therapeutics? Sign up to receive the latest short interest report for Inhibitor Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartINTI Short Interest Over TimeINTI Days to Cover Over TimeINTI Percentage of Float Shorted Over Time Inhibitor Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/30/2025700 shares $34.79 No ChangeN/A0.1 $0.05 9/15/2025700 shares $41.93 -96.1%N/A0.1 $0.06 8/31/202518,000 shares $795.60 +56.5%0.0%1 $0.04 8/15/202511,500 shares $460.00 No ChangeN/A0.3 $0.04 7/31/202511,500 shares $629.05 +59.7%0.0%1.9 $0.05 7/15/20257,200 shares $352.80 +44.0%N/A3 $0.05 6/30/20255,000 shares $209.00 -48.5%0.0%0.6 $0.04 6/15/20259,700 shares $470.92 No Change0.0%0.6 $0.05 5/15/20257,200 shares $403.20 -72.1%0.0%0.2 $0.06 4/30/202525,800 shares $1.59 thousand +218.5%N/A0.5 $0.06 Get the Latest News and Ratings for INTI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Inhibitor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/15/20258,100 shares $406.94 +22.7%0.0%0.2 $0.05 3/31/20256,600 shares $330.00 -68.7%0.0%0.1 $0.05 3/15/202521,100 shares $1.48 thousand -60.9%0.0%0.7 $0.07 2/28/202553,900 shares $3.55 thousand +36.8%0.0%539 $0.07 2/15/202539,400 shares $2.60 thousand +471.0%0.0%0.5 $0.07 1/31/20256,900 shares $396.75 No ChangeN/A0.4 $0.06 1/15/202520,300 shares $1.22 thousand -49.9%N/A0.7 $0.06 12/31/202420,300 shares $1.22 thousand -49.9%N/A0.7 $0.06 12/15/202440,500 shares $3.00 thousand +841.9%N/A0.2 $0.07 11/30/20244,300 shares $331.10 -43.4%N/A0.1 $0.08 11/15/20247,600 shares $608.00 -32.7%N/A0.1 $0.08 10/31/202411,300 shares $960.50 No ChangeN/A0.4 $0.09 7/15/2024100 shares $8.50 -50.0%N/A1 $0.09 6/30/2024200 shares $15.80 -86.7%N/A0.1 $0.08 6/15/20241,500 shares $105.15 +15.4%N/A5 $0.07 5/31/20241,300 shares $113.88 No ChangeN/A0.1 $0.09 4/30/20242,300 shares $197.80 No ChangeN/A1.8 $0.09 4/15/20242,300 shares $178.25 +360.0%N/A0.5 $0.08 3/31/2024500 shares $35.00 +400.0%N/A0 $0.07 3/15/2024100 shares $7.70 -99.6%N/A0 $0.08 2/29/202424,800 shares $1.98 thousand No ChangeN/A0.5 $0.08 11/30/2023100 shares $9.05 -94.1%N/A0 $0.09 11/15/20231,700 shares $204.00 +1,600.0%N/A0.1 $0.12 10/31/2023100 shares $5.15 -98.2%N/A0 $0.05 10/15/20235,600 shares $268.80 No ChangeN/A1 $0.05 9/30/20235,600 shares $302.40 -73.1%N/A0.4 $0.05 9/15/202320,800 shares $1.12 thousand No ChangeN/A0.3 $0.05 8/15/20232,400 shares $49.92 No ChangeN/A0 $0.02 5/31/20231,500 shares $48.00 -25.0%N/A0.2 $0.03 5/15/20232,000 shares $78.00 No ChangeN/A0.1 $0.04 11/15/20223,300 shares $198.00 +37.5%N/A0.1 $0.06 10/31/20222,400 shares $117.12 No ChangeN/A3 $0.05 10/15/20222,400 shares $105.48 No ChangeN/A4.8 $0.04 9/30/20222,400 shares $123.60 +118.2%N/A0.2 $0.05 9/15/20221,100 shares $97.68 No ChangeN/A0 $0.09 8/31/20221,100 shares $97.68 No ChangeN/A0 $0.09 4/30/2022100 shares $14.38 No ChangeN/A0.3 $0.14 4/15/2022100 shares $14.39 -50.0%N/A0 $0.14 3/31/2022200 shares $26.10 No ChangeN/A0.3 $0.13 3/15/2022200 shares $31.56 No ChangeN/A2 $0.16 2/28/2022200 shares $31.56 No ChangeN/A0.7 $0.16 2/15/2022200 shares $26.07 No ChangeN/A0.1 $0.13 1/31/2022200 shares $26.11 No ChangeN/A0.1 $0.13 11/15/20212,000 shares $318.60 No ChangeN/A0.1 $0.16 10/15/20213,000 shares $480.00 No ChangeN/A0.1 $0.16 9/30/20213,000 shares $450.90 +500.0%N/A0.3 $0.15 9/15/2021500 shares $61.05 -16.7%N/A0.5 $0.12 8/31/2021600 shares $79.80 No ChangeN/A0 $0.13 8/13/2021600 shares $120.18 No ChangeN/A0 $0.20 7/30/2021600 shares $144.00 -79.3%N/A0.1 $0.24 7/15/20212,900 shares $697.45 +26.1%N/A0.8 $0.24 6/30/20212,300 shares $553.38 +2,200.0%N/A0 $0.24 6/15/2021100 shares $12.00 -88.9%N/A0 $0.12 5/28/2021900 shares $71.01 -10.0%N/A0.1 $0.08 5/14/20211,000 shares $75.20 +900.0%N/A0.1 $0.08 4/30/2021100 shares $6.50 -98.4%N/A0 $0.07 4/15/20216,300 shares $472.50 +65.8%N/A0.8 $0.08 3/31/20213,800 shares $286.90 +660.0%N/A0.6 $0.08 3/15/2021500 shares $55.00 No ChangeN/A0 $0.11 2/12/20218,500 shares $462.40 No ChangeN/A0.2 $0.05 11/30/2020200 shares $7.44 No ChangeN/A0 $0.04 INTI Short Interest - Frequently Asked Questions What is Inhibitor Therapeutics' current short interest? Short interest is the volume of Inhibitor Therapeutics shares that have been sold short but have not yet been covered or closed out. As of September 30th, investors have sold 700 shares of INTI short. Learn More on Inhibitor Therapeutics' current short interest. How does Inhibitor Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Inhibitor Therapeutics: Rani Therapeutics Holdings, Inc. (0.41%), SCYNEXIS, Inc. (2.29%), ImageneBio, Inc. (0.44%), Exicure, Inc. (1.95%), Provectus Biopharmaceuticals, Inc. (0.15%), Kezar Life Sciences, Inc. (12.16%), Akari Therapeutics PLC (0.46%), Rein Therapeutics Inc. (0.08%), Sonnet BioTherapeutics Holdings, Inc. (32.77%), IntelGenx Technologies Corp. (0.01%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($15.71 billion), Robinhood Markets, Inc. ($7.56 billion), Reddit Inc. ($4.55 billion), Coinbase Global, Inc. ($4.53 billion), CoreWeave Inc. ($4.43 billion), Charter Communications, Inc. ($4.07 billion), Seagate Technology Holdings PLC ($3.94 billion), IonQ, Inc. ($3.78 billion), TC Energy Corporation ($3.13 billion), and Live Nation Entertainment, Inc. ($3.12 billion). View all of the most shorted stocks. What does it mean to sell short Inhibitor Therapeutics stock? Short selling INTI is an investing strategy that aims to generate trading profit from Inhibitor Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Inhibitor Therapeutics? A short squeeze for Inhibitor Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INTI, which in turn drives the price of the stock up even further. How often is Inhibitor Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INTI, twice per month. The most recent reporting period available is September, 30 2025. More Short Interest Resources from MarketBeat Related Companies RANI Short Interest SCYX Short Interest IMA Short Interest XCUR Short Interest PVCT Short Interest KZR Short Interest AKTX Short Interest RNTX Short Interest SONN Short Interest IGXT Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:INTI) was last updated on 10/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inhibitor Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inhibitor Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
